Dr. Matthew Williams

Consultant Clinical Oncologist at Imperial College Healthcare NHS Trust and Honorary Senior Fellow at Imperial College, London, UK.

Country

United Kingdom

Speciality

Oncology

Subspeciality

Neuro-Oncology

Experience

1999 years

Languages

English

Areas of expertise

Neuro-oncology
Bone metastases
Chemotherapy
Cyberknife
Intensity-modulated radiation therapy (IMRT)
Brain metastases
Glioma
Glioblastoma
Oligondendroglioma
Ependymoma
Gamma Knife
Optune/ tumour-treating fields (TTF)
Palliative Radiotherapy
Brain tumour chemotherapy
Brain tumour radiotherapy
Stereotactic radiotherapy
SRS

About the expert

Dr. Williams is currently a Consultant Clinical Oncologist at Imperial College Healthcare NHS Trust. He specialises in the treatment of brain tumours, including benign and malignant tumours and brain metastases. He has expanded the use of a second course of radiotherapy (re-irradiation), particularly in combination with chemotherapy. He is one of the few clinicians in the UK to have experience across the range of all three stereotactic platforms (LINAC, CyberKnife and GammaKnife) for delivering highly focused radiotherapy. He leads the Computational Oncology group at Imperial College, where his research focuses on the application of technology and computing to improve cancer care. He also helped found the Advanced Therapies Group at Imperial, which explores the integration of cutting-edge research and clinical practice to deliver novel therapies to patients with brain tumours. He took part in the first UK expanded access scheme to use Optune widely, and runs the UK's largest Optune clinic.

Dr Williams completed his undergradute studies in Birmingham, before moving to London where he trained at the Hammersmith Hospital. He completed his clinical oncology training in London, followed by a PhD with the Advanced Computation Lab at CRUK/UCL. He was appointed as a Consultant at Imperial College Healthcare NHS Trust in February 2012, where he specialises in neuro-oncology and is joint MDT lead for neuro-oncology.

He is an Honorary Senior Fellow at Imperial College, where he leads the Computational Oncology Group. He sits on the NCRI Brain Tumour clinical trials group, and has a particular interest in studies looking at novel approaches to improving current treatments in neuro-oncology.

He chairs the neuro-oncology MDT at The London Clinic, and has worked to make The London Clinic the only site in the UK that offers the INTRAGO-II trial (Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme)

Dr. Williams' current clinical focus is on the delivery of novel drugs and drug/radiotherapy combinations for patients with primary and metastatic brain tumours. He took part in the first UK expanded access scheme to use Optune widely, and runs the UK's largest Optune clinic. Dr Matthews is one of the few people experienced across all three main stereotactic modalities (Gamma Knife, Cyberknife, and LINAC-based SRS). He also helped found the Advanced Therapies Group at Imperial, which explores the integration of cutting-edge research and clinical practice to deliver novel therapies to patients with brain tumours.

Dr Williams supervises a range of PhD/MD students with Imperial College researching and studying projects. He teaches about brain tumours on a European course in oncology and led the London ICR course module on brain tumours for several years.

Consultant in Clinical Oncology
2012 - Today
Imperial College Healthcare NHS Trust
Honorary Clinical Senior Lecturer
2012 - Today
Imperial College
Clinical Oncology Registrar
2010 - 2013
UCLH NHS Foundation Trust
Clinical Research Fellow in Computer Science.
2004 - 2008
Cancer Research Center, UK
Head of Accident and Emergency Departement

The Gambia Hospital
Senior House Officer

Hammersmith Hospital

PhD in Advanced Computation Lab

University College London (Cancer Research Center)

2008
Membership

Royal College of Physicians (MRCP)

2002
Bachelor of Medicine and Bachelor of Surgery

Birmingham University

1999
Bachelor of Medical Sciences in Pharmacology

Birmingham University

1996

https://bmjopen.bmj.com/content/11/7/e053076

Other experts inthe same speciality

Doctor Premini Mahendra

Consultant Haemato-Oncologist, Birmingham, United Kingdom

More about the expert

Professor Jaak Janssens

Former head of oncology department – Limburg Oncological Center, Belgium.

More about the expert

Dr. Rafael Moleron

Consultant Clinical Oncologist at Aberdeen Royal Infirmary

More about the expert

Dr. Russell Banner

Consultant Clinical Oncologist in the South West Wales Cancer Centre

More about the expert

Doctor Ahmed Salem

Consultant Clinical Oncology at The Christie Hospital, Manchester, UK.

More about the expert

Prof. Mehmet Sen

Clinical oncologist, St James`s Institute of Oncology, Leeds, UK.

More about the expert

Professor Thierry Le Chevalier

Head of the Institute of Thoracic Oncology at Gustave Roussy Hospital in Villejuif, France, and Marie Lannelongue Hospital in Le Plessis Robinson, France.

More about the expert

Doctor Derek Grose

Consultant Clinical Oncologist & Honorary Senior Lecturer at the Beatson West of Scotland Cancer Center, UK.

More about the expert

Doctor Claire Paterson

Consultant Clinical Oncologist & Honorary Senior Lecturer at University of Glasgow and Beatson West of Scotland Cancer Center, Scotland.

More about the expert

Doctor Ioanna Nixon

Consultant Clinical Oncologist at the Beatson West of Scotland Cancer Center, Lead for the Scottish Sarcoma Network and Visiting Professor at Strathclyde University, Glasgow, UK

More about the expert